Follicular Lymphoma
Long-Term Survivorship
Since FL is generally characterized by multiple disease relapses after responses to a variety of treatments, patients in remission should have regular visits with a physician who is familiar with their medical history and the treatments they have received. Medical tests (such as blood tests and computed tomography [CT] or positron emission tomography [PET] scans, and biopsies of suspicious masses or the pelvic bone marrow) may be required at various times during remission to evaluate the need for additional treatment.
Some treatments can cause long-term effects or late effects, which can vary based on duration and frequency of treatments, age, gender, and the overall health of each patient at the time of treatment. A physician will check for these effects during follow-up care. Visits may become less frequent the longer the disease remains in remission.
Patients and their caregivers are encouraged to keep copies of all medical records and test results as well as information on the types, amounts, and duration of all treatments received. This documentation will be important for keeping track of any effects resulting from treatment or potential disease recurrences.
Learn More
To learn more about long-term survivorship, download the Lymphoma Survivorship Fact Sheet Series. Want to talk to someone? For answers to lymphoma-related questions and resources, contact our Helpline at (800) 500-9976 or helpline@lymphoma.org.
Additional Resources
To learn more about FL, download the Follicular Lymphoma Fact Sheet.
Events
-
Lymphoma Talk: Minneapolis
Minneapolis Marriott City Center 30 South 7th Street, Minneapolis, MinnesotaLymphoma Talk is a two-hour weekday evening in-person program led by lymphoma experts that provides […]
-
Living with Lymphoma
Virtual EventLiving with Lymphoma provides the latest information about lymphoma diagnosis, current treatment options, and patient […]
-
What Care Partners Should Know Webinar
Virtual EventWebinars are hour-long interactive programs discussing the diagnosis and treatment of specific lymphoma subtypes and […]